DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Given Average Recommendation of “Hold” by Brokerages

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) has earned an average recommendation of “Hold” from the nine brokerages that are covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $29.50.

A number of brokerages have recently commented on XRAY. Needham & Company LLC cut their price target on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Evercore ISI cut their price target on shares of DENTSPLY SIRONA from $29.00 to $27.00 and set an “outperform” rating on the stock in a report on Tuesday, October 8th. Leerink Partners lowered shares of DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a report on Thursday, November 7th. Barrington Research dropped their target price on shares of DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Finally, Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th.

DENTSPLY SIRONA Trading Up 2.3 %

NASDAQ XRAY opened at $19.64 on Thursday. The firm’s fifty day moving average price is $22.97 and its two-hundred day moving average price is $24.93. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA has a fifty-two week low of $17.21 and a fifty-two week high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping analysts’ consensus estimates of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s revenue was up .4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 earnings per share. As a group, sell-side analysts forecast that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Hedge Funds Weigh In On DENTSPLY SIRONA

Several institutional investors have recently made changes to their positions in the stock. Raymond James Trust N.A. raised its holdings in shares of DENTSPLY SIRONA by 4.9% during the second quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after purchasing an additional 453 shares during the period. State of Alaska Department of Revenue increased its position in shares of DENTSPLY SIRONA by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after acquiring an additional 560 shares in the last quarter. LRI Investments LLC increased its position in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after acquiring an additional 564 shares in the last quarter. Diversified Trust Co increased its position in shares of DENTSPLY SIRONA by 3.0% during the second quarter. Diversified Trust Co now owns 19,637 shares of the medical instruments supplier’s stock worth $489,000 after acquiring an additional 566 shares in the last quarter. Finally, MML Investors Services LLC increased its position in shares of DENTSPLY SIRONA by 2.1% during the third quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock worth $803,000 after acquiring an additional 620 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.